AZTR
Price
$0.22
Change
-$0.01 (-4.35%)
Updated
Jul 25 closing price
Capitalization
3.72M
23 days until earnings call
MMIRF
Price
$0.05
Change
+$0.04 (+400.00%)
Updated
Jul 22 closing price
Capitalization
38.69M
Interact to see
Advertisement

AZTR vs MMIRF

Header iconAZTR vs MMIRF Comparison
Open Charts AZTR vs MMIRFBanner chart's image
Azitra
Price$0.22
Change-$0.01 (-4.35%)
Volume$1.08M
Capitalization3.72M
Medmira
Price$0.05
Change+$0.04 (+400.00%)
Volume$1.5K
Capitalization38.69M
AZTR vs MMIRF Comparison Chart in %
Loading...
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AZTR vs. MMIRF commentary
Jul 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTR is a StrongBuy and MMIRF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2025
Stock price -- (AZTR: $0.22 vs. MMIRF: $0.05)
Brand notoriety: AZTR and MMIRF are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AZTR: 42% vs. MMIRF: 18%
Market capitalization -- AZTR: $3.72M vs. MMIRF: $38.69M
AZTR [@Biotechnology] is valued at $3.72M. MMIRF’s [@Biotechnology] market capitalization is $38.69M. The market cap for tickers in the [@Biotechnology] industry ranges from $313.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.57B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTR’s FA Score shows that 1 FA rating(s) are green whileMMIRF’s FA Score has 1 green FA rating(s).

  • AZTR’s FA Score: 1 green, 4 red.
  • MMIRF’s FA Score: 1 green, 4 red.
According to our system of comparison, MMIRF is a better buy in the long-term than AZTR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTR’s TA Score shows that 4 TA indicator(s) are bullish while MMIRF’s TA Score has 3 bullish TA indicator(s).

  • AZTR’s TA Score: 4 bullish, 4 bearish.
  • MMIRF’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AZTR is a better buy in the short-term than MMIRF.

Price Growth

AZTR (@Biotechnology) experienced а -4.89% price change this week, while MMIRF (@Biotechnology) price change was +257.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.58%. For the same industry, the average monthly price growth was +17.35%, and the average quarterly price growth was +27.29%.

Reported Earning Dates

AZTR is expected to report earnings on Aug 18, 2025.

MMIRF is expected to report earnings on Jul 01, 2025.

Industries' Descriptions

@Biotechnology (+7.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MMIRF($38.7M) has a higher market cap than AZTR($3.72M). MMIRF YTD gains are higher at: 282.443 vs. AZTR (-49.260). MMIRF has higher annual earnings (EBITDA): -3.24M vs. AZTR (-8.63M). AZTR has more cash in the bank: 3.21M vs. MMIRF (18.3K). AZTR has less debt than MMIRF: AZTR (474K) vs MMIRF (10.2M). MMIRF has higher revenues than AZTR: MMIRF (254K) vs AZTR (7.5K).
AZTRMMIRFAZTR / MMIRF
Capitalization3.72M38.7M10%
EBITDA-8.63M-3.24M267%
Gain YTD-49.260282.443-17%
P/E Ratio0.13N/A-
Revenue7.5K254K3%
Total Cash3.21M18.3K17,525%
Total Debt474K10.2M5%
FUNDAMENTALS RATINGS
MMIRF: Fundamental Ratings
MMIRF
OUTLOOK RATING
1..100
46
VALUATION
overvalued / fair valued / undervalued
1..100
5
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
36
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AZTRMMIRF
RSI
ODDS (%)
Bullish Trend 1 day ago
88%
Bearish Trend 1 day ago
84%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
64%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
52%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
57%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 26 days ago
81%
N/A
Declines
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AZTR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MMIRF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOSCF15.11N/A
N/A
Tosoh Corp.
CATWF0.07N/A
N/A
China Tontine Wines Group Ltd.
NZERF0.16N/A
N/A
New Zealand Energy Corp.
PLRRF6.40N/A
N/A
Polar Capital Holdings PLC
DLICY15.94-0.13
-0.81%
Dai-ichi Life Holdings Inc

AZTR and

Correlation & Price change

A.I.dvisor indicates that over the last year, AZTR has been closely correlated with DARE. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if AZTR jumps, then DARE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AZTR
1D Price
Change %
AZTR100%
-4.34%
DARE - AZTR
73%
Closely correlated
-2.28%
SLRX - AZTR
42%
Loosely correlated
-0.17%
SAGE - AZTR
35%
Loosely correlated
+0.46%
SNTI - AZTR
31%
Poorly correlated
-3.02%
KNSA - AZTR
26%
Poorly correlated
-2.12%
More

MMIRF and

Correlation & Price change

A.I.dvisor tells us that MMIRF and NWPHF have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MMIRF and NWPHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MMIRF
1D Price
Change %
MMIRF100%
N/A
NWPHF - MMIRF
30%
Poorly correlated
N/A
TECX - MMIRF
29%
Poorly correlated
+0.18%
AZTR - MMIRF
24%
Poorly correlated
-4.34%
SRPT - MMIRF
22%
Poorly correlated
-7.38%
SAGE - MMIRF
22%
Poorly correlated
+0.46%
More